Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-14-000751

CEO gave up 15,023 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LEWIS JONATHAN CEO 2013-12-31 Shares withheld for taxes −15,023 $4.34 $65,200 509,753 D
Derivatives
LEWIS JONATHAN CEO 2013-12-31 Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000 D
Loading xslF345X03/doc4.xml…